Reactive Biosciences
Elk Park
About Reactive Biosciences
Reactive Biosciences is a discovery platform to discover and develop medicines in innovative and imaginative new ways. Reactive utilizes the world's foremost boron-based discovery platform to explore inventive and imaginative avenues for medicine discovery and development. Leveraging the distinctive properties of boron, they aim to target unexplored binding sites and advance therapeutics in traditionally deemed undruggable areas. Their objective is to create impactful medicines capable of profoundly altering the trajectory of diseases, positively impacting patients and their families. Reactive seeks partnerships with companies aiming to expedite transformative medicine discovery and development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $100K – $500K
- Total funding: $43.0M
- Last round: Debt Financing (Jun 2023)
- Website: reactivebio.com
- Phone: 984-569-4261
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/reactive-biosciences-96375 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.